Tumor-derived exosomes (TDEs) are actively produced and released by tumor cells and
carry messages from tumor cells to healthy cells or abnormal cells, and they participate in …

Abstract Malignant Pleural Mesothelioma (MPM) is currently an incurable cancer with a
typical survival of 1 year from the time of diagnosis. The recent genomic and transcriptomic …

Introduction Nodal categories for malignant pleural mesothelioma are derived from the lung
cancer staging system and have not been adequately validated. The International …

Abstract Rationale and Objectives It is still a challenge to make confirming diagnosis of
malignant pleural mesothelioma (MPM), especially differentiating from metastatic pleural …

Malignant mesothelioma (MM) is a highly aggressive and lethal cancer with a poor survival
rate. Current treatment approaches primarily rely on chemotherapy and radiation, but their …

Background and objectives Diagnosis of tuberculous pleurisy (TP) may be challenging and
it often requires pleural biopsy. A tool able to increase pre-test probability of TP may be …

Objective To compare the multidetector CT (MDCT) features of malignant pleural
mesothelioma (MPM) and metastatic pleural disease (MPD). Materials and Methods The …

Objectives The role of postoperative radiotherapy (PORT) in malignant pleural
mesothelioma (MPM) remains controversial and the eighth edition TNM staging scheme for …

Primary intrahepatic malignant mesothelioma (PIHMM) is an extremely rare tumor with
clinicopathological characteristics that remain to be elucidated. The current study presents …

Malignant pleural mesothelioma (MPM) is a very important public health issue. A large
amount of data indicates a relationship between mesothelioma and asbestos exposure. The …